Compare iShares S&P GSCI Commodity-Indexed Trust ETF (GSG) vs HCA Health Inc (HCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares S&P GSCI Commodity-Indexed Trust ETF vs HCA Health Inc — how do they compare? iShares S&P GSCI Commodity-Indexed Trust ETF trades at $32.32, while HCA Health Inc trades at $411.04 (market cap $89.76B). The key difference: HCA Health Inc pays a 0.75% dividend while iShares S&P GSCI Commodity-Indexed Trust ETF pays none, and iShares S&P GSCI Commodity-Indexed Trust ETF is trading nearer its 52-week high, HCA Health Inc nearer its low. Which is the better fit depends on your goals.
| GSG | HCA | |
|---|---|---|
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $34.77 | $545.13 |
52-Week Low | $22.06 | $361.32 |
Market Cap | — | $89.76B |
Enterprise Value | — | $140.30B |
Dividend Yield | — | 0.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSG (iShares S&P GSCI Commodity-Indexed Trust ETF) trades at $32.62, up 0.31% with a bullish technical signal driven by strong moving average alignment. The ETF's performance remains heavily tied to energy commodities, which drove strong H1 2026 results but face increased volatility. Recent analyst commentary reflects caution despite the technical momentum.
The outlook for GSG depends on commodity market dynamics, particularly energy prices. While technical indicators suggest near-term strength, fundamental risks include commodity price volatility and geopolitical factors. Investors should weigh the ETF's energy concentration against broader market conditions for balanced exposure.
HCA Healthcare trades at $411.74, up slightly by 0.07% in the last session, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.60 billion in 2025, with a net income margin of 8.77%, while the P/E ratio of 13.9 suggests reasonable valuation. Recent corporate actions include quarterly dividends of $0.78, and analyst consensus is a Buy with a $449.93 price target. However, legal investigations announced in August 2026 pose near-term sentiment risks.
The outlook for HCA remains positive due to steady revenue growth and operational efficiency, but investors face risks from rising expenses and regulatory scrutiny. Upside potential exists if the company maintains earnings momentum and resolves legal concerns, while downside risks include increased debt levels and competitive pressures in the healthcare sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares S&P GSCI Commodity-Indexed Trust ETF
GSG is a diversified commodity ETF that tracks the S&P GSCI Total Return Index. It provides exposure to a broad basket of futures, including energy, metals, and agriculture, with a significant weighting toward the energy sector.
Read more on GSG →About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →
